These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23478277)

  • 1. Lipoprotein-associated phospholipase A2 (Lp-PLA(2)): a novel and promising biomarker for cardiovascular risks assessment.
    Cai A; Zheng D; Qiu R; Mai W; Zhou Y
    Dis Markers; 2013; 34(5):323-31. PubMed ID: 23478277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lp-PLA2: A new target for statin therapy.
    Braun LT; Davidson MH
    Curr Atheroscler Rep; 2010 Jan; 12(1):29-33. PubMed ID: 20425268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.
    Rosenson RS; Stafforini DM
    J Lipid Res; 2012 Sep; 53(9):1767-82. PubMed ID: 22665167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
    Davidson MH; Corson MA; Alberts MJ; Anderson JL; Gorelick PB; Jones PH; Lerman A; McConnell JP; Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):51F-57F. PubMed ID: 18549872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques].
    Bonnefont-Rousselot D
    Ann Pharm Fr; 2016 May; 74(3):190-7. PubMed ID: 26499399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lipoprotein-associated phospholipase A2 (Lp-PLA₂) in cardiovascular disease.
    Ikonomidis I; Michalakeas CA; Lekakis J; Parissis J; Anastasiou-Nana M
    Rev Recent Clin Trials; 2011 May; 6(2):108-13. PubMed ID: 21241231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
    Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
    Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2.
    Zhang H; Zhang JY; Sun TW; Shen DL; He F; Dang YH; Li L
    Clin Invest Med; 2013 Feb; 36(1):E32-41. PubMed ID: 23374598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lp-PLA(2) as a marker of cardiovascular diseases.
    Bhatti S; Hakeem A; Cilingiroglu M
    Curr Atheroscler Rep; 2010 Mar; 12(2):140-4. PubMed ID: 20425250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
    Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
    J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
    Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
    Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
    Madjid M; Ali M; Willerson JT
    Tex Heart Inst J; 2010; 37(1):25-39. PubMed ID: 20200624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
    Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD
    J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2).
    Tselepis AF; Rizzo M; Goudevenos IA
    Curr Pharm Des; 2011 Nov; 17(33):3656-61. PubMed ID: 22074435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lipoprotein-associated phospholipase A(2) and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Garg PK; McClelland RL; Jenny NS; Criqui M; Liu K; Polak JF; Jorgensen NW; Cushman M
    Vasc Med; 2011 Aug; 16(4):247-52. PubMed ID: 21708876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.
    Gong HP; Du YM; Zhong LN; Dong ZQ; Wang X; Mao YJ; Lu QH
    Lipids Health Dis; 2011 Jan; 10():13. PubMed ID: 21247435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.
    Toth PP; McCullough PA; Wegner MS; Colley KJ
    Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):425-38. PubMed ID: 20222820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.